Cetuximab (C), oxaliplatin (Ox) and fluoropyrimidine (Fp): Toxicity during the first 12 weeks of treatment for the first 804 patients entered into the MRC COIN (CR10) trial

4070 Background: COIN is a 3-arm trial comparing continuous chemotherapy (CT) plus C or intermittent CT with standard continuous CT (OxFp) in the first-line treatment of advanced colorectal cancer ...